Skip to content

Author

Oya Korkmaz

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

From subclinical ovarian damage to reproductive outcomes: a translational perspective on PI3K/AKT/mTOR signaling in fertility preservation.

A unifying "subclinical damage-signaling-outcome axis" linking early molecular injury and signaling dysregulation with subsequent reproductive consequences, including impaired oocyte quality and adverse fertility outcomes is proposed.

Oya Korkmaz · 0 citations
Open access Aug 2026

COMPARATIVE EFFECTS OF RESVERATROL AND CAFFEIC ACID ON CELL VIABILITY, APOPTOSIS, AND PTEN/AKT1 SIGNALING IN MCF-7 BREAST CANCER CELLS

Objective: This study evaluates the effects of resveratrol and caffeic acid on viability, proliferation, and apoptosis in ER⁺ MCF-7 breast cancer cells, with additional analysis of PTEN/AKT1-related transcriptional changes. Methods: MCF-7 cells were exposed to resveratrol at concentrations ranging from 5 to 50 µM and t...

Oya Korkmaz · 0 citations
Aug 2026

Follicular kisspeptin-VEGF axis in polycystic ovary syndrome and ovarian hyperstimulation syndrome.

Follicular fluid levels of Kisspeptin-1, Kisspeptin-54, and VEGF are significantly elevated in ovarian hyperresponse conditions and exhibit strong associations with key indicators of ovarian stimulation outcomes, suggesting that Kisspeptin-54 and VEGF reflect the biological features of ovarian hyperresponsiveness and m...

Oya Korkmaz, S. Karabulut, Pelin Macit · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.